Zoll has completed its previously announced acquisition of certain assets of Vyaire Medical’s ventilator business.
RT’s Three Key Takeaways:
- Acquisition Finalized: Zoll has completed its acquisition of select ventilator product lines from Vyaire Medical. They are bellavista, fabian*, LTV, and 3100 HFOV.
- Expanded Respiratory Portfolio: Zoll will immediately make available to customers the bellavista, fabian*, LTV, and 3100 HFOV product lines.
- Ongoing Support for Customers: During the transition, Vyaire’s existing contact channels will remain active.
Zoll, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it completed its previously announced acquisition of certain assets of Vyaire Medical’s ventilator business.
With the acquisition complete, Zoll will immediately make available to customers the bellavista, fabian*, LTV, and 3100 HFOV product lines alongside Zoll’s other respiratory care offerings.
“Zoll’s acquisition of select Vyaire ventilator product lines is an exciting opportunity for our customers and our company,” says Jon Rennert, CEO of Zoll, in a press release. “We now have the ability to serve even more patients and customers, furthering our mission of improving patient outcomes and helping save lives.”
For these acquired product lines, all ventilators and associated consumables, service parts, accessories, and service program offerings will continue to be sold where currently available. Existing Vyaire contact channels will remain available for use during a transition period.
Customers can also contact Zoll at [email protected].
*Not available for sale in the US.
Photo caption: bellavista 1000e
File photo
